Ser1034
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Phosphorylation Site Page:
Ser1034 - InsR (rat)

Site Information
LRELGQGsFGMVYEG    SwissProt Entrez-Gene
Predicted information: Scansite
Orthologous residues: InsR (human): S1033, InsR (mouse): S1023, InsR iso2 (human): S1021
Blast this site against: NCBI  SwissProt  PDB 

In vivo Characterization
Methods used to characterize site in vivo: immunoprecipitation (2), phospho-antibody (1, 2, 3), western blotting (1)
Relevant cell line - cell type - tissue: 'muscle, skeletal' (3), liver (1, 2, 3)

Controlled by
Regulatory protein: InsR (rat) (3)
Putative upstream kinases: TBK1 (rat) (1)
Kinases, in vitro: TBK1 (human) (1)
Treatments: insulin (1, 2, 3), irbesartan (1, 2), TNF (1)



References

1

Muñoz MC, et al. (2009) TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. J Endocrinol 201, 185-97
19251743   Curated Info

2

Muñoz MC, et al. (2006) Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens 24, 1607-17
16877964   Curated Info

3

Coba MP, et al. (2004) Increased in vivo phosphorylation of insulin receptor at serine 994 in the liver of obese insulin-resistant Zucker rats. J Endocrinol 182, 433-44
15350185   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.